Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients | Zendy

Uyen Duong | Zendy; Kamyar KalantarZadeh | Zendy; Miklos Z. Molnar | Zendy; Joshua J. Zaritsky | Zendy; Isaac Teitelbaum | Zendy; Csaba P. Kövesdy | Zendy; Rajnish Mehrotra | Zendy

Open Access

Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients

Author(s) -

Uyen Duong,

Kamyar KalantarZadeh,

Miklos Z. Molnar,

Joshua J. Zaritsky,

Isaac Teitelbaum,

Csaba P. Kövesdy,

Rajnish Mehrotra

Publication year - 2012

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000335685

Subject(s) - medicine , hemodialysis , peritoneal dialysis , hazard ratio , kidney disease , proportional hazards model , gastroenterology , dialysis , poisson regression , anemia , nephrology , surgery , confidence interval , population , environmental health

Several studies have shown an association between erythropoietin-stimulating agent (ESA) responsiveness and mortality in chronic kidney disease (CKD) patients. In our present study, we examined the association between prescribed ESA dose and mortality in peritoneal dialysis (PD) and hemodialysis (HD) patients. We hypothesized that PD patients received lower ESA dose for the same achieved hemoglobin compared to HD patients and that ESA dose-mortality associations were different between PD and HD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research